• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease.早发性帕金森病中 PRKN、LRRK2 和 GBA 携带者的认知障碍自我报告和简易精神状态检查表现。
J Clin Exp Neuropsychol. 2010 Aug;32(7):775-9. doi: 10.1080/13803390903521018. Epub 2010 Feb 24.
2
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.早发性帕金森病 GBA 突变携带者的认知表现:CORE-PD 研究。
Neurology. 2012 May 1;78(18):1434-40. doi: 10.1212/WNL.0b013e318253d54b. Epub 2012 Mar 21.
3
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.伴有和不伴有GBA突变的帕金森病中的葡萄糖脑苷脂酶活性
Brain. 2015 Sep;138(Pt 9):2648-58. doi: 10.1093/brain/awv179. Epub 2015 Jun 27.
4
Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutations.帕金森病伴 GBA 突变患者双侧丘脑底核脑深部电刺激术后早期认知减退。
Parkinsonism Relat Disord. 2020 Jul;76:56-62. doi: 10.1016/j.parkreldis.2020.04.002. Epub 2020 Jun 9.
5
Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson's disease: Risk estimates and genotype-phenotype correlations.帕金森病患者同时携带 GBA 和 LRRK2 突变与仅携带其中一种突变相比:风险估计和基因型-表型相关性。
Parkinsonism Relat Disord. 2019 May;62:179-184. doi: 10.1016/j.parkreldis.2018.12.014. Epub 2018 Dec 13.
6
Features of -associated Parkinson's disease at presentation in the UK study.英国研究中 - 关联帕金森病的发病特征。
J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):702-709. doi: 10.1136/jnnp-2017-317348. Epub 2018 Jan 29.
7
Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.LRRK2(富含亮氨酸重复激酶 2)和 GBA(β-葡糖苷脂酶)帕金森病患者的临床和多巴胺转运体成像特征:帕金森进展标志物倡议的横断面研究。
Mov Disord. 2020 May;35(5):833-844. doi: 10.1002/mds.27989. Epub 2020 Feb 19.
8
New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin.针对 GBA、LRRK2 和 Parkin 的帕金森病新治疗方法。
Neuropharmacology. 2022 Jan 1;202:108822. doi: 10.1016/j.neuropharm.2021.108822. Epub 2021 Oct 7.
9
Mutations in the Parkinson's disease genes, Leucine Rich Repeat Kinase 2 (LRRK2) and Glucocerebrosidase (GBA), are not associated with essential tremor.帕金森病基因,富亮氨酸重复激酶 2(LRRK2)和葡萄糖脑苷脂酶(GBA)的突变与特发性震颤无关。
Parkinsonism Relat Disord. 2010 Feb;16(2):132-5. doi: 10.1016/j.parkreldis.2009.05.008. Epub 2009 Jun 13.
10
Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriers.淡漠:GBA 和 LRRK2 非表现型突变携带者中被低估的特征。
Parkinsonism Relat Disord. 2021 Oct;91:1-8. doi: 10.1016/j.parkreldis.2021.08.008. Epub 2021 Aug 18.

引用本文的文献

1
Cognitive Decline in Parkinsonism: From Clinical Phenotypes to the Genetic Background.帕金森病中的认知衰退:从临床表型到遗传背景
Biomedicines. 2025 Jul 2;13(7):1624. doi: 10.3390/biomedicines13071624.
2
Emerging perspectives on precision therapy for Parkinson's disease: multidimensional evidence leading to a new breakthrough in personalized medicine.帕金森病精准治疗的新视角:通向个性化医疗新突破的多维度证据
Front Aging Neurosci. 2024 Jul 4;16:1417515. doi: 10.3389/fnagi.2024.1417515. eCollection 2024.
3
Neurological Insights into Sleep Disorders in Parkinson's Disease.帕金森病睡眠障碍的神经学见解
Brain Sci. 2023 Aug 14;13(8):1202. doi: 10.3390/brainsci13081202.
4
Neuronopathic GBA1L444P Mutation Accelerates Glucosylsphingosine Levels and Formation of Hippocampal Alpha-Synuclein Inclusions.神经元病 GBA1L444P 突变加速了葡萄糖脑苷脂神经酰胺水平的升高和海马α-突触核蛋白包涵体的形成。
J Neurosci. 2023 Jan 18;43(3):501-521. doi: 10.1523/JNEUROSCI.0680-22.2022. Epub 2022 Dec 7.
5
Cognitive Impairment in Genetic Parkinson's Disease.遗传性帕金森病中的认知障碍
Parkinsons Dis. 2021 Dec 30;2021:8610285. doi: 10.1155/2021/8610285. eCollection 2021.
6
Different Associated Factors of Subjective Cognitive Complaints in Patients With Early- and Late-Onset Parkinson's Disease.早发型和晚发型帕金森病患者主观认知障碍的不同相关因素
Front Neurol. 2021 Nov 23;12:749471. doi: 10.3389/fneur.2021.749471. eCollection 2021.
7
Best early-onset Parkinson dementia predictor using ensemble learning among Parkinson's symptoms, rapid eye movement sleep disorder, and neuropsychological profile.在帕金森症状、快速眼动睡眠障碍和神经心理特征中使用集成学习的最佳早发性帕金森痴呆预测指标。
World J Psychiatry. 2020 Nov 19;10(11):245-259. doi: 10.5498/wjp.v10.i11.245.
8
Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study.在一项基于英国大型人群的帕金森病研究中对孟德尔突变进行的遗传分析。
Brain. 2019 Sep 1;142(9):2828-2844. doi: 10.1093/brain/awz191.
9
The Neuropsychiatric and Motor Profile of -Associated Parkinson's Disease: A Review.与[具体内容缺失]相关的帕金森病的神经精神和运动特征:综述。
Mov Disord Clin Pract. 2015 Sep 16;3(1):4-8. doi: 10.1002/mdc3.12229. eCollection 2016 Jan-Feb.
10
Cognitive decline in Parkinson disease.帕金森病患者的认知能力下降。
Nat Rev Neurol. 2017 Apr;13(4):217-231. doi: 10.1038/nrneurol.2017.27. Epub 2017 Mar 3.

本文引用的文献

1
Association of glucocerebrosidase mutations with dementia with lewy bodies.葡萄糖脑苷脂酶突变与路易体痴呆的关联。
Arch Neurol. 2009 May;66(5):578-83. doi: 10.1001/archneurol.2009.54.
2
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease.临床及病理确诊帕金森病中的葡萄糖脑苷脂酶突变
Brain. 2009 Jul;132(Pt 7):1783-94. doi: 10.1093/brain/awp044. Epub 2009 Mar 13.
3
A multidisciplinary study of patients with early-onset PD with and without parkin mutations.一项针对有和没有帕金基因突变的早发性帕金森病患者的多学科研究。
Neurology. 2009 Jan 13;72(2):110-6. doi: 10.1212/01.wnl.0000327098.86861.d4. Epub 2008 Nov 5.
4
Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease.荷兰早发性帕金森病患者的基因型和表型特征。
Mov Disord. 2009 Jan 30;24(2):196-203. doi: 10.1002/mds.22287.
5
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force.帕金森病痴呆的诊断程序:运动障碍协会特别工作组的建议
Mov Disord. 2007 Dec;22(16):2314-24. doi: 10.1002/mds.21844.
6
Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.葡萄糖脑苷脂酶基因突变与早发性帕金森病相关。
Neurology. 2007 Sep 18;69(12):1270-7. doi: 10.1212/01.wnl.0000276989.17578.02.
7
Construction and validation of a Parkinson's disease mutation genotyping array for the Parkin gene.用于帕金基因的帕金森病突变基因分型阵列的构建与验证
Mov Disord. 2007 May 15;22(7):932-7. doi: 10.1002/mds.21419.
8
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.早发型和晚发型帕金森病中LRRK2突变的频率
Neurology. 2006 Nov 28;67(10):1786-91. doi: 10.1212/01.wnl.0000244345.49809.36. Epub 2006 Oct 18.
9
Case-control study of the parkin gene in early-onset Parkinson disease.早发性帕金森病中帕金基因的病例对照研究。
Arch Neurol. 2006 Apr;63(4):548-52. doi: 10.1001/archneur.63.4.548.
10
Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism.早发性帕金森综合征的流行病学、临床及遗传学特征
Lancet Neurol. 2006 Apr;5(4):355-63. doi: 10.1016/S1474-4422(06)70411-2.

早发性帕金森病中 PRKN、LRRK2 和 GBA 携带者的认知障碍自我报告和简易精神状态检查表现。

Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease.

机构信息

Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.

出版信息

J Clin Exp Neuropsychol. 2010 Aug;32(7):775-9. doi: 10.1080/13803390903521018. Epub 2010 Feb 24.

DOI:10.1080/13803390903521018
PMID:20182943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2911493/
Abstract

While little is known about risk factors for cognitive impairment in early onset Parkinson disease (EOPD), postmortem studies have shown an association between dementia with Lewy bodies (DLB) and glucocerebrosidase (GBA) mutation. We compared Mini-Mental State Examination (MMSE) performance and self-reported cognitive impairment in 699 EOPD participants genotyped for mutations in parkin (PRKN), leucine-rich repeat kinase-2 (LRRK2), and GBA. Logistic regression was used to assess the association between reported cognitive impairment and MMSE score, as well as between GBA group membership and self-reported impairment and MMSE. GBA carriers reported more impairment, but MMSE performance did not differ among genetic groups. Detailed neuropsychological testing is required to explore the association between cognitive impairment and GBA mutations.

摘要

虽然对于早发性帕金森病(EOPD)认知障碍的风险因素知之甚少,但尸检研究表明,路易体痴呆(DLB)和葡萄糖脑苷脂酶(GBA)突变之间存在关联。我们比较了 699 名 EOPD 参与者的简易精神状态检查(MMSE)表现和自我报告的认知障碍,这些参与者的基因型为 parkin(PRKN)、富亮氨酸重复激酶-2(LRRK2)和 GBA 突变。Logistic 回归用于评估报告的认知障碍与 MMSE 评分之间的关联,以及 GBA 组与自我报告的障碍和 MMSE 之间的关联。GBA 携带者报告的障碍更多,但遗传组之间的 MMSE 表现没有差异。需要进行详细的神经心理学测试来探索认知障碍与 GBA 突变之间的关联。